Eurex and Premialab have launched standardized, centrally cleared futures on Quantitative Investment Strategies (QIS) indices - a major milestone in bringing systematic strategies from the OTC market into the listed space. Pierre Trecourt, Co-Founder of Premialab, and Elena Marchidann, Global Product Lead – Total Return Derivatives at Eurex, recently discussed how the new QIS futures segment broadens institutional access, streamlines implementation, and enhances portfolio efficiency through improved transparency, liquidity, and cross-margining benefits.

Watch the recording to gain insights into:

• The evolving role of systematic strategies in institutional portfolios and their growing adoption across asset allocators
• How the futurization of QIS exposures provides more efficient and scalable market access
• The operational and regulatory advantages of QIS Index Futures relative to traditional OTC structures